ReviewCancers2023

Phosphoinositide 3-Kinase (PI3K) Inhibitors and Breast Cancer: An Overview of Current Achievements.

Alexandre Bertucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.